A practical reference on IGF-1: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-04-11 and is reviewed periodically as new material appears.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
At the end of the 1950s, the USSR constructed the first satellite—Sputnik 1, which marked the beginning of the Space Race—a competition to achieve superior spaceflight capability with the United States. This was followed by other successful satellites, most notably Sputnik 5, where test dogs were sent to space. On 12 April 1961, the USSR launched Vostok 1, which carried Yuri Gagarin, making him the first human to ever be launched into space and complete a space journey. The first plans for space shuttles and orbital stations were drawn up in Soviet design offices, but personal disputes between designers and management prevented their development. In terms of the Luna program, the USSR only had automated spacecraft launches with no crewed spacecraft. The N1—a Super heavy-lift launch vehicle intended to match the American Saturn V for a Soviet crewed moon landing—failed all four of its test launches, and the 'Moon' part of Space Race was won by the Americans. The Soviet public's reaction to the American moon-landing was mixed. The Soviet government limited the release of information about it, which affected the reaction. A portion of the populace did not give it attention, and another portion was angered. In the 1970s, specific proposals for the design of a space shuttle emerged, but shortcomings, especially in the electronics industry (rapid overheating of electronics), postponed it till the end of the 1980s. The first shuttle, the Buran, flew in 1988, but without a human crew. Another, Ptichka, endured prolonged construction and was canceled in 1991.
The primary purpose of the altitude chamber is for the subjects to learn what their hypoxia symptoms are. The symptoms of hypoxia are different for each individual, and this training is helpful for aviators to be able to recognize these symptoms during actual flight so as to avoid in-flight oxygen emergencies. Military pilots who fly aircraft at altitudes in excess of 10,000 feet, and civilian pilots who fly unpressurized aircraft above 12,500 feet, must use oxygen equipment. Altitude chamber training is required of U.S. military aviators every five years. The FAA and some larger airlines also require their pilots to periodically take altitude chamber training. Anyone with a pilot certificate in the United States who has a current Class I or Class II medical certificate can normally sign up and receive altitude training from several commercial facilities and a very limited availability from a government facility. There are many procedures followed during chamber training for aircrew. Usually new aircrew will undergo a familiarization profile, where the chamber ascends to an altitude of 10,000 ft. During the ascent they are instructed on the proper procedure to clear the ears. During ascent, students are asked to yawn and on descent they need to perform the valsalva maneuver. If they perform the valsalva during ascent, they risk suffering barotrauma of the ear. This is because the ears are susceptible to Boyle's law. There are also other profiles, such a hypoxia training profile, where the chamber ascends to an altitude of 25,000 ft.
=== Neuropsychiatric disorders === Methylene blue inhibits monoamine oxidase, inhibits the glutamatergic system (via inhibition of NO synthase and soluble guanylate cyclase), modulates mitochondrial function (by acting as an electron acceptor), and decreases the activation of inflammasomes NLRP3 and NLRC4. As a result, it's been considered potentially useful in neuropsychiatric disorders. In humans it has been tried for (listed in decreasing order of evidence quality): bipolar disorder (especially depressive symptoms), Alzheimer's disease, claustrophobia, ifosfamide encephalopathy, and schizophrenia. With methylene blue, a higher dose does not necessarily work better than a lower dose.
The Somali community has been a source of many significant poets, writers, and Islamic figures over the years, a considerable proportion of whom have played a pivotal role in influencing and moulding the trajectory of Muslim scholarship and traditions, not just in the Horn of Africa but also reaching far into the Arabian Peninsula and other regions around the world. Somalia has also been called by, among others, the Canadian novelist and scholar Margaret Laurence, a "Nation of Poets" and a "Nation of Bards". Famed British explorer and writer Richard Burton wrote that many Somalis are exceptionally familiar with literature and poetry. With the adoption of the Latin alphabet in 1972 as the nation's standard orthography, numerous contemporary Somali authors have also released novels, some of which have received worldwide acclaim. Among these modern authors, Nuruddin Farah is the most renowned, receiving, among other honours, the 1998 Neustadt international prize for Literature. Faarax M.J. Cawl is another notable Somali author who is famous for his novel set in the Dervish era, Ignorance is the enemy of love. Somali poetry also thrived during this era with Hadraawi gaining national renown for his prose and poetry.
=== In space === The 2021 Plant Habitat-04 experiment aboard the International Space Station grew four chili plants in 137 days, producing twenty-six peppers across two harvests. Most were eaten by the crew; twelve were returned to Earth for study. The plants were a specially dwarfed variety of the Hatch cultivar. This was the "first generally recognized fruiting crop in space", following harvests of leaf crops such as lettuce and kale from 2014 onwards.
Sources: en.wikipedia.org
==== Specific populations ==== Modafinil exhibits sex-specific pharmacokinetic differences. It demonstrates higher bioavailability in women compared to men. The mean Cmax is higher in women than in men, 5.2 mg/L vs. 4.2 mg/L (p < 0.05), following a single 200 mg oral dose of modafinil. This difference persists even after adjusting for body weight (0.88 ml/min/kg vs. 0.72 ml/min/kg). The clearance of modafinil is 30% higher in men than in women, and plasma concentrations after a single dose are significantly higher in women than in men. These sex-specific pharmacokinetic differences may have implications for the efficacy and safety of modafinil.
The amino acid score is based on the proportion of amino acids in a food, compared to nutritional requirements. As such, only essential amino acids are considered in the two most common measurements of quality, the PDCAAS and the DIAAS. The following is a table of the amino acid profiles of some common protein sources, not accounting for digestibility. The requirement profile is the required amounts of an amino acid in every 100 g of protein in the Dietary Reference Intake. Each profile reflects the amount of an amino acid per 100 g of protein, not 100 g of the food source. In considering protein quality, the sulfur amino acids (methionine + cystine) and the aromatic amino acids (phenylalanine + tyrosine) are grouped together. This is because while methionine and phenylalanine are essential amino acids, cystine and tyrosine are synthesized from methione and phenylalanine, respectively. Nevertheless, common protein analytical methods such as ISO 13903 can easily distinguish these pairs of amino acids. Additionally, glutamic acid is easilty interconvertible with glutamine and aspartic acid is easily interconvertible with asparginine. easily interconvertible, via acid hydrolysis. Thus, common amino acid analysis methods such as ISO 13903 only measure glutamic acid and aspartic acid, not glutamine or asparginine, and these measured values may be treated as a sum of the two. Selenocysteine is usually not measured as part of amino acid analysis. It is usually analyzed directly as the amount of selenium, which mostly occurs as selenomethionine and selenocysteine in food.
The primary combat vehicles of the American divisions were the M1A1 Abrams tank and the Bradley Fighting Vehicle. The primary American artillery system was the self propelled M109 howitzer. The primary American attack helicopter was the Boeing AH-64 Apache (Army) with the Bell AH-1 Cobra (Army and Marines) also being in theatre. The U.S. Fairchild Republic A-10 Thunderbolt II ground attack aircraft would distinguish itself during the Gulf War aided by the OH-58D JAATT eyes in the sky. Together they inflicted significant damage on Iraqi ground forces. U.S. A-10 "Warthog" crews would destroy 900 Iraqi tanks, 2,000 other military vehicles and 1,200 artillery pieces during combat operations. The U.S. Marine Corps was represented by the 1st Marine Division and the 2nd Marine Division. They were supported by the U.S. Army's 2nd Armored Division's Tiger Brigade to provide the Marines with additional armor support. Marine armor units mostly consisted of the older M-60 tank. The 1st Marine Division destroyed around 60 Iraqi tanks near the Burgan oil field without suffering any losses. The 1st Marine Division Task Force Ripper led the drive to the Kuwait International Airport on 27 February 1991. Marine Task Force Ripper destroyed about 100 Iraqi tanks and armored personnel carriers, including T-72 tanks. The division commander Maj. Gen. J.M. Myatt said, "During the first day of combat operations 1st Platoon, D Company, 3rd Tank Battalion destroyed 15 Iraqi tanks". The Marines also destroyed 25 APCs and took 300 prisoners of war. The U.S.M.C.
=== Blood parameters === During acute inflammatory periods, people with AS may show an increase in the blood concentration of CRP and an increase in the ESR, but there are many with AS whose CRP and ESR rates do not increase, so normal CRP and ESR results do not always correspond with the amount of inflammation that is actually present. In other words, some people with AS have normal levels of CRP and ESR, despite experiencing a significant amount of inflammation in their bodies.
Sources: en.wikipedia.org
=== MALDI-imaging mass spectrometry === Due to MALDI being a soft ionization source, it is used on a wide variety of biomolecules. This has led to it being used in new ways such as MALDI-imaging mass spectrometry. This technique allows for the imaging of the spatial distribution of biomolecules.
=== Chesapeake Bay restoration === Moore said he would support Chesapeake Bay restoration efforts by promoting "accountability and enforcement" in Maryland, as well as in neighboring states, use federal funds to upgrade water and wastewater systems, and by increasing the number of environmental inspectors. In October 2022, he told Lancaster Farming that he would develop a plan to accelerate projects to improve water quality and cut carbon emissions in his administration's first 100 days, and supported the restoration of the state's Chesapeake Bay Restoration Fund. In July 2023, Moore signed executive orders to refocus cleanup efforts onto shallow areas of the bay and to establish the Council on the Chesapeake and Coastal Bays to research state policy on oyster restoration and harvesting. From October 2023 to December 2025, Moore served as the chair of the Chesapeake Executive Council. During the 2025 legislative session, Moore introduced the Bay Legacy Act, which would promote regenerative farming practices on public lands, increase support for agricultural and oyster farmers, and improve the Maryland Department of Natural Resources's water quality monitoring methods. The Bay Legacy Act passed and was signed into law by Moore in May 2025. In December 2025, Moore, Delaware Governor Matt Meyer, Virginia Governor Glenn Youngkin, and Pennsylvania Governor Josh Shapiro approved a new cleanup plan that extended the Chesapeake Bay restoration effort to 2040 and includes commitments to reducing sediment pollution to the Bay.
Negative-pressure wound therapy (NPWT), also known as a vacuum assisted closure (VAC), is a therapeutic technique using a suction pump, tubing, and a dressing to remove excess wound exudate and to promote healing in acute or chronic wounds and second- and third-degree burns. The use of this technique in wound management started in the 1990s and this technique is often recommended for treatment of a range of wounds including dehisced surgical wounds, closed surgical wounds, open abdominal wounds, open fractures, pressure injuries or pressure ulcers, diabetic foot ulcers, venous insufficiency ulcers, some types of skin grafts, burns, and sternal wounds. It may also be considered after a clean surgery in a person who is obese. NPWT is performed by applying a sub-atmospheric vacuum through a special sealed dressing. The continued vacuum draws out fluid from the wound and increases blood flow to the area. The vacuum may be applied continuously or intermittently, depending on the type of wound being treated and the clinical objectives. Typically, the dressing is changed two to three times per week. The dressings used for the technique include foam dressings, sealed with an occlusive dressing intended to contain the vacuum at the wound site. Where NPWT devices allow delivery of fluids, such as saline or antibiotics to irrigate the wound, intermittent removal of used fluid supports the cleaning and drainage of the wound bed. In 1995, Kinetic Concepts was the first company to have a NPWT product cleared by the US Food and Drug Administration.
G cells have a distinctive microscopic appearance that allows one to separate them from other cells in the gastric antrum; their nuclei are centrally located in the cell. They are found in the middle portion of the gastric glands.
Hogan, C.Michael (2010). "Laurus Nobilis L." Encyclopedia of Life. Retrieved 2010-12-30. MeSH: Laurus – Laurus nobilis (Bay Laurel) PubMed search: "Laurus"[MAJR] Laurus nobilis – Israel Wildflowers and native plants
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.